Literature DB >> 35937033

Disentangling Whether from When in a Neural Mixture Cure Model for Failure Time Data.

Matthew Engelhard1, Ricardo Henao1.   

Abstract

The mixture cure model allows failure probability to be estimated separately from failure timing in settings wherein failure never occurs in a subset of the population. In this paper, we draw on insights from representation learning and causal inference to develop a neural network based mixture cure model that is free of distributional assumptions, yielding improved prediction of failure timing, yet still effectively disentangles information about failure timing from information about failure probability. Our approach also mitigates effects of selection biases in the observation of failure and censoring times on estimation of the failure density and censoring density, respectively. Results suggest this approach could be applied to distinguish factors predicting failure occurrence versus timing and mitigate biases in real-world observational datasets.

Entities:  

Year:  2022        PMID: 35937033      PMCID: PMC9355098     

Source DB:  PubMed          Journal:  Proc Mach Learn Res


  15 in total

1.  The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis.

Authors:  L J Wei
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

2.  Mixture cure model with random effects for clustered interval-censored survival data.

Authors:  Liming Xiang; Xiangmei Ma; Kelvin K W Yau
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

3.  Under the radar: how unexamined biases in decision-making processes in clinical interactions can contribute to health care disparities.

Authors:  John F Dovidio; Susan T Fiske
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

4.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

5.  The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments.

Authors:  W A Knaus; F E Harrell; J Lynn; L Goldman; R S Phillips; A F Connors; N V Dawson; W J Fulkerson; R M Califf; N Desbiens; P Layde; R K Oye; P E Bellamy; R B Hakim; D P Wagner
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

6.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

7.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

8.  Adversarial Time-to-Event Modeling.

Authors:  Paidamoyo Chapfuwa; Chenyang Tao; Chunyuan Li; Courtney Page; Benjamin Goldstein; Lawrence Carin; Ricardo Henao
Journal:  Proc Mach Learn Res       Date:  2018-07

9.  Completeness of Follow-Up Determines Validity of Study Findings: Results of a Prospective Repeated Measures Cohort Study.

Authors:  Regula S von Allmen; Salome Weiss; Hendrik T Tevaearai; Christoph Kuemmerli; Christian Tinner; Thierry P Carrel; Juerg Schmidli; Florian Dick
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

10.  DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network.

Authors:  Jared L Katzman; Uri Shaham; Alexander Cloninger; Jonathan Bates; Tingting Jiang; Yuval Kluger
Journal:  BMC Med Res Methodol       Date:  2018-02-26       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.